🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

RecruitingNAAges 18 Years - 75 YearsAllThe Hospital for Sick Children
NCT05968807 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Mentee Inclusion Criteria: * Parent of a patient under 18 years of age who received a solid organ transplant and is at least two months post-transplant, * Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and * English-speaking. Mentor Inclusion Criteria: * Parent of a patient under 21 years of age who received a solid organ transplant and is at least one year post-transplant, * Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network), * Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and * English-speaking. Exclusion Criteria: * Non-English speaking.
💊

What it tests

  • iParent2Parent Program
📍

Where

1 site
Hospital for Sick Children
Toronto, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy